Yahoo Finance

BullFrog AI and Eleison Pharmaceuticals Enter Agreement to Collaborate to Optimize Pivotal Phase 3 Trial

GAITHERSBURG, Md., Feb. 27, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial ...
Nasdaq

Windtree and Eleison Announce Initial Results of Delivering Inhaled Lipid Cisplatin (ILC) Utilizing Windtree's Drug Delivery Technology

WARRINGTON, Pa. and PRINCETON, N.J., June 4, 2019 /PRNewswire/ -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates ...
Nasdaq

BullFrog AI Partners With Eleison Pharmaceuticals To Optimize Phase 3 Pancreatic Cancer Trial

(RTTNews) - BullFrog AI Holdings, Inc. (BFRG) has entered into a collaboration agreement with Eleison Pharmaceuticals Inc. to optimize clinical trials for glufosfamide, an investigational treatment ...
GlobalData on MSN

BullFrog AI partners with Eleison to enhance Phase III trial

BullFrog AI Holdings has announced a partnership agreement with Eleison Pharmaceuticals to apply its artificial intelligence ...
Yahoo Finance

BullFrog AI’s bfPREP™ and bfLEAP® Platforms Deliver Real-World Impact in Eleison Pharmaceuticals Collaboration

GAITHERSBURG, Md., Sept. 08, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial ...
Hosted on MSN

Bullfrog AI provides update on collaboration with Eleison

BullFrog AI (BFRG) Holdings provided an update on its collaboration with Eleison Pharmaceuticals. To support this collaboration, BullFrog AI developed a new data ingestion module, purpose-built to ...